Kymera Therapeutics

Kymera Therapeutics Appoints Juliet Williams, PhD, as Senior Vice President, Head of Biology

WATERTOWN, Mass., May 05, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the appointment of Juliet Williams, PhD, as